Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119,358,581
-
Total 13F shares
-
38,573,613
-
Share change
-
+1,142,364
-
Total reported value
-
$379,945,234
-
Put/Call ratio
-
0%
-
Price per share
-
$9.85
-
Number of holders
-
115
-
Value change
-
+$12,021,170
-
Number of buys
-
55
-
Number of sells
-
47
Institutional Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q3 2018
As of 30 Sep 2018,
CYTOKINETICS INC - COMMON STOCK (CYTK) was held by
115 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,573,613 shares.
The largest 10 holders included
BlackRock Inc., BVF INC/IL, Vanguard Group Inc, LANSDOWNE PARTNERS (UK) LLP, GREAT POINT PARTNERS LLC, STATE STREET CORP, FMR LLC, WASATCH ADVISORS INC, WELLINGTON MANAGEMENT GROUP LLP, and Invesco Ltd..
This page lists
115
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.